Global N-Glycan Site Occupancy of HIV-1 gp120 by Metabolic Engineering and High-Resolution Intact Mass Spectrometry

ACS Chemical Biology

Volumn 12, Issue 2, 2017, Pages 357-361

  Struwe, Weston B ^a   Stuckmann, Alexandra ^b   Behrens, Anna Janina ^a   Pagel, Kevin ^b   Crispin, Max ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; KIFUNENSINE; MONOMER; RECOMBINANT GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 120; POLYSACCHARIDE;

ARTICLE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MASS SPECTROMETER; MASS SPECTROMETRY; METABOLIC ENGINEERING; MOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; TRANSIENT EXPRESSION; VIRUS STRAIN; BINDING SITE; METABOLISM; PROCEDURES;

BINDING SITES; HIV ENVELOPE PROTEIN GP120; HIV-1; MASS SPECTROMETRY; METABOLIC ENGINEERING; POLYSACCHARIDES;

EID: 85013378365     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/acschembio.6b00854     Document Type: Article

References (39)

1. Scanlan, C. N., Offer, J., Zitzmann, N., and Dwek, R. A. (2007) Exploiting the defensive sugars of HIV-1 for drug and vaccine design Nature 446, 1038-1045 10.1038/nature05818
2. Lyumkis, D., Julien, J. P., de Val, N., Cupo, A., Potter, C. S., Klasse, P. J., Burton, D. R., Sanders, R. W., Moore, J. P., Carragher, B., Wilson, I. A., and Ward, A. B. (2013) Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer Science 342, 1484-1490 10.1126/science.1245627
3. Julien, J. P., Cupo, A., Sok, D., Stanfield, R. L., Lyumkis, D., Deller, M. C., Klasse, P. J., Burton, D. R., Sanders, R. W., Moore, J. P., Ward, A. B., and Wilson, I. A. (2013) Crystal structure of a soluble cleaved HIV-1 envelope trimer Science 342, 1477-1483 10.1126/science.1245625
4. Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., and Sodroski, J. G. (1998) The antigenic structure of the HIV gp120 envelope glycoprotein Nature 393, 705-711 10.1038/31514
5. Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., Komarova, N. L., Nowak, M. A., Hahn, B. H., Kwong, P. D., and Shaw, G. M. (2003) Antibody neutralization and escape by HIV-1 Nature 422, 307-312 10.1038/nature01470
6. Moore, J. P. and Sodroski, J. (1996) Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein J. Virol. 70, 1863-1872
7. Stewart-Jones, G. B., Soto, C., Lemmin, T., Chuang, G. Y., Druz, A., Kong, R., Thomas, P. V., Wagh, K., Zhou, T., Behrens, A. J., Bylund, T., Choi, C. W., Davison, J. R., Georgiev, I. S., Joyce, M. G., Kwon, Y. D., Pancera, M., Taft, J., Yang, Y., Zhang, B., Shivatare, S. S., Shivatare, V. S., Lee, C. C., Wu, C. Y., Bewley, C. A., Burton, D. R., Koff, W. C., Connors, M., Crispin, M., Baxa, U., Korber, B. T., Wong, C. H., Mascola, J. R., and Kwong, P. D. (2016) Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G Cell 165, 813-826 10.1016/j.cell.2016.04.010
8. Burton, D. R. and Mascola, J. R. (2015) Antibody responses to envelope glycoproteins in HIV-1 infection Nat. Immunol. 16, 571-576 10.1038/ni.3158
9. Crispin, M. and Doores, K. J. (2015) Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design Curr. Opin. Virol. 11, 63-69 10.1016/j.coviro.2015.02.002
10. Shingai, M., Donau, O. K., Plishka, R. J., Buckler-White, A., Mascola, J. R., Nabel, G. J., Nason, M. C., Montefiori, D., Moldt, B., Poignard, P., Diskin, R., Bjorkman, P. J., Eckhaus, M. A., Klein, F., Mouquet, H., Cetrulo Lorenzi, J. C., Gazumyan, A., Burton, D. R., Nussenzweig, M. C., Martin, M. A., and Nishimura, Y. (2014) Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques J. Exp. Med. 211, 2061-2074 10.1084/jem.20132494
11. Burton, D. R., Ahmed, R., Barouch, D. H., Butera, S. T., Crotty, S., Godzik, A., Kaufmann, D. E., McElrath, M. J., Nussenzweig, M. C., Pulendran, B., Scanlan, C. N., Schief, W. R., Silvestri, G., Streeck, H., Walker, B. D., Walker, L. M., Ward, A. B., Wilson, I. A., and Wyatt, R. (2012) A Blueprint for HIV Vaccine Discovery Cell Host Microbe 12, 396-407 10.1016/j.chom.2012.09.008
12. Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P. S., Wang, S. K., Stanfield, R. L., Julien, J. P., Ramos, A., Crispin, M., Depetris, R., Katpally, U., Marozsan, A., Cupo, A., Maloveste, S., Liu, Y., McBride, R., Ito, Y., Sanders, R. W., Ogohara, C., Paulson, J. C., Feizi, T., Scanlan, C. N., Wong, C. H., Moore, J. P., Olson, W. C., Ward, A. B., Poignard, P., Schief, W. R., Burton, D. R., and Wilson, I. A. (2011) A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield Science 334, 1097-1103 10.1126/science.1213256
13. Pancera, M., Shahzad-Ul-Hussan, S., Doria-Rose, N. A., McLellan, J. S., Bailer, R. T., Dai, K., Loesgen, S., Louder, M. K., Staupe, R. P., Yang, Y., Zhang, B., Parks, R., Eudailey, J., Lloyd, K. E., Blinn, J., Alam, S. M., Haynes, B. F., Amin, M. N., Wang, L. X., Burton, D. R., Koff, W. C., Nabel, G. J., Mascola, J. R., Bewley, C. A., and Kwong, P. D. (2013) Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16 Nat. Struct. Mol. Biol. 20, 804-813 10.1038/nsmb.2600
14. Coss, K. P., Vasiljevic, S., Pritchard, L. K., Krumm, S. A., Glaze, M., Madzorera, S., Moore, P. L., Crispin, M., and Doores, K. J. (2016) HIV-1 glycan density drives the persistence of the mannose patch within an infected individual J. Virol. 90, 11132 10.1128/JVI.01542-16
15. Townsley, S., Mohamed, Z., Guo, W., McKenna, J., Cleveland, B., LaBranche, C., Beaumont, D., Shen, X., Yates, N. L., Pinter, A., Tomaras, G. D., Ferrari, G., Montefiori, D. C., and Hu, S. L. (2016) Induction of heterologous Tier 2 HIV-1 neutralizing and cross-reactive V1/V2-specific antibodies in rabbits by prime-boost immunization J. Virol. 90, 8644 10.1128/JVI.00853-16
16. Crooks, E. T., Tong, T., Chakrabarti, B., Narayan, K., Georgiev, I. S., Menis, S., Huang, X., Kulp, D., Osawa, K., Muranaka, J., Stewart-Jones, G., Destefano, J., O'Dell, S., LaBranche, C., Robinson, J. E., Montefiori, D. C., McKee, K., Du, S. X., Doria-Rose, N., Kwong, P. D., Mascola, J. R., Zhu, P., Schief, W. R., Wyatt, R. T., Whalen, R. G., and Binley, J. M. (2015) Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site PLoS Pathog. 11, e1004932 10.1371/journal.ppat.1004932
17. Fournier, J. (2015) A Review of Glycan Analysis Requirements BioPharm. Int. 28, 32-37
18. Lewis, G. K., DeVico, A. L., and Gallo, R. C. (2014) Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development Proc. Natl. Acad. Sci. U. S. A. 111, 15614-15621 10.1073/pnas.1413550111
19. Jardine, J., Julien, J. P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P. S., MacPherson, S., Jones, M., Nieusma, T., Mathison, J., Baker, D., Ward, A. B., Burton, D. R., Stamatatos, L., Nemazee, D., Wilson, I. A., and Schief, W. R. (2013) Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors Science 340, 711-716 10.1126/science.1234150
20. de Taeye, S. W., Ozorowski, G., Torrents de la Pena, A., Guttman, M., Julien, J. P., van den Kerkhof, T. L., Burger, J. A., Pritchard, L. K., Pugach, P., Yasmeen, A., Crampton, J., Hu, J., Bontjer, I., Torres, J. L., Arendt, H., DeStefano, J., Koff, W. C., Schuitemaker, H., Eggink, D., Berkhout, B., Dean, H., LaBranche, C., Crotty, S., Crispin, M., Montefiori, D. C., Klasse, P. J., Lee, K. K., Moore, J. P., Wilson, I. A., Ward, A. B., and Sanders, R. W. (2015) Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes Cell 163, 1702-1715 10.1016/j.cell.2015.11.056
21. Rudd, P. M. and Dwek, R. A. (1997) Glycosylation: heterogeneity and the 3D structure of proteins Crit. Rev. Biochem. Mol. Biol. 32, 1-100 10.3109/10409239709085144
22. Behrens, A. J., Vasiljevic, S., Pritchard, L. K., Harvey, D. J., Andev, R. S., Krumm, S. A., Struwe, W. B., Cupo, A., Kumar, A., Zitzmann, N., Seabright, G. E., Kramer, H. B., Spencer, D. I., Royle, L., Lee, J. H., Klasse, P. J., Burton, D. R., Wilson, I. A., Ward, A. B., Sanders, R. W., Moore, J. P., Doores, K. J., and Crispin, M. (2016) Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein Cell Rep. 14, 2695-2706 10.1016/j.celrep.2016.02.058
23. Go, E. P., Herschhorn, A., Gu, C., Castillo-Menendez, L., Zhang, S., Mao, Y., Chen, H., Ding, H., Wakefield, J. K., Hua, D., Liao, H. X., Kappes, J. C., Sodroski, J., and Desaire, H. (2015) Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140 J. Virol. 89, 8245-8257 10.1128/JVI.00628-15
24. Behrens, A. J., Harvey, D. J., Milne, E., Cupo, A., Kumar, A., Zitzmann, N., Struwe, W. B., Moore, J. P., and Crispin, M. (2016) Molecular architecture of the cleavage-dependent mannose patch on a soluble HIV-1 envelope glycoprotein trimer J. Virol. JVI.01894-16 10.1128/JVI.01894-16
25. Zhu, Z., Go, E. P., and Desaire, H. (2014) Absolute quantitation of glycosylation site occupancy using isotopically labeled standards and LC-MS J. Am. Soc. Mass Spectrom. 25, 1012-1017 10.1007/s13361-014-0859-2
26. Go, E. P., Liao, H. X., Alam, S. M., Hua, D., Haynes, B. F., and Desaire, H. (2013) Characterization of host-cell line specific glycosylation profiles of early transmitted/founder HIV-1 gp120 envelope proteins J. Proteome Res. 12, 1223-1234 10.1021/pr300870t
27. Hernandez, H. and Robinson, C. V. (2007) Determining the stoichiometry and interactions of macromolecular assemblies from mass spectrometry Nat. Protoc. 2, 715-726 10.1038/nprot.2007.73
28. Elbein, A. D., Tropea, J. E., Mitchell, M., and Kaushal, G. P. (1990) Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I J. Biol. Chem. 265, 15599-15605
29. Gault, J., Donlan, J. A., Liko, I., Hopper, J. T., Gupta, K., Housden, N. G., Struwe, W. B., Marty, M. T., Mize, T., Bechara, C., Zhu, Y., Wu, B., Kleanthous, C., Belov, M., Damoc, E., Makarov, A., and Robinson, C. V. (2016) High-resolution mass spectrometry of small molecules bound to membrane proteins Nat. Methods 13, 333-336 10.1038/nmeth.3771
30. Yang, Y., Barendregt, A., Kamerling, J. P., and Heck, A. J. (2013) Analyzing protein micro-heterogeneity in chicken ovalbumin by high-resolution native mass spectrometry exposes qualitatively and semi-quantitatively 59 proteoforms Anal. Chem. 85, 12037-12045 10.1021/ac403057y
31. Rosati, S., van den Bremer, E. T., Schuurman, J., Parren, P. W., Kamerling, J. P., and Heck, A. J. (2013) In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified Orbitrap mAbs 5, 917-924 10.4161/mabs.26282
32. Parsons, T. B., Struwe, W. B., Gault, J., Yamamoto, K., Taylor, T. A., Raj, R., Wals, K., Mohammed, S., Robinson, C. V., Benesch, J. L., and Davis, B. G. (2016) Optimal Synthetic Glycosylation of a Therapeutic Antibody Angew. Chem., Int. Ed. 55, 2361-2367 10.1002/anie.201508723
33. Chang, V. T., Crispin, M., Aricescu, A. R., Harvey, D. J., Nettleship, J. E., Fennelly, J. A., Yu, C., Boles, K. S., Evans, E. J., Stuart, D. I., Dwek, R. A., Jones, E. Y., Owens, R. J., and Davis, S. J. (2007) Glycoprotein structural genomics: solving the glycosylation problem Structure 15, 267-273 10.1016/j.str.2007.01.011
34. Crispin, M., Bowden, T. A., Coles, C. H., Harlos, K., Aricescu, A. R., Harvey, D. J., Stuart, D. I., and Jones, E. Y. (2009) Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions J. Mol. Biol. 387, 1061-1066 10.1016/j.jmb.2009.02.033
35. Scanlan, C. N., Ritchie, G. E., Baruah, K., Crispin, M., Harvey, D. J., Singer, B. B., Lucka, L., Wormald, M. R., Wentworth, P., Jr., Zitzmann, N., Rudd, P. M., Burton, D. R., and Dwek, R. A. (2007) Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody J. Mol. Biol. 372, 16-22 10.1016/j.jmb.2007.06.027
36. Harvey, D. J., Scarff, C. A., Edgeworth, M., Struwe, W. B., Pagel, K., Thalassinos, K., Crispin, M., and Scrivens, J. (2016) Travelling-wave ion mobility and negative ion fragmentation of high-mannose N-glycans J. Mass Spectrom. 51, 219-235 10.1002/jms.3738
37. Stephenson, K. E., D'Couto, H. T., and Barouch, D. H. (2016) New concepts in HIV-1 vaccine development Curr. Opin. Immunol. 41, 39-46 10.1016/j.coi.2016.05.011
38. Stansell, E., Panico, M., Canis, K., Pang, P. C., Bouche, L., Binet, D., O'Connor, M. J., Chertova, E., Bess, J., Lifson, J. D., Haslam, S. M., Morris, H. R., Desrosiers, R. C., and Dell, A. (2015) Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate PLoS One 10, e0124784 10.1371/journal.pone.0124784
39. Lingg, N., Zhang, P., Song, Z., and Bardor, M. (2012) The sweet tooth of biopharmaceuticals: importance of recombinant protein glycosylation analysis Biotechnol. J. 7, 1462-1472 10.1002/biot.201200078